QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Teladoc Health, Inc. (TDOC)

Healthcare

Actionable
Fundamental
3
Sentiment
3
Technical
4

Buy limit 8.76 (pullback to the bull-flag low 8.75/8.76 and rising EMA9 8.74) with a structure-based stop 8.28 (Change-A 1.0×ATR floor below entry; structural swingLow-buffer 8.32 is tighter) and targets 9.72 (2.0×ATR) / 10.44 (3.5×ATR); R/R 2.00, all Step-00 gates passed.

Analysis as of 2026-11-12· more than 2 trading days ago

Company overview

Teladoc Health, Inc. provides remote medical services across the United States and internationally, addressing a wide range of health needs from routine care to complex conditions. The company offers virtual medical care, chronic disease management, mental wellness support, and expert second opinions under brands like Teladoc, Livongo, and BetterHelp.

Fundamental

fair
Fundamental3
Mixed fundamentals

Teladoc is cash-generative but faces revenue decline and BetterHelp contraction, with valuation undemanding yet profitability weak.

Cash-generative but shrinking: positive operating and free cash flow, net debt under 1x EBITDA, a clean going-concern and covenant picture, and a cheap multiple (EV/sales 0.79, FCF yield about 7.9%) — offset by three straight years of revenue decline, a double-digit BetterHelp contraction with a further Q4 guide-down, GAAP losses, a $1.0B convertible note due June 2027 and high share-price volatility. Mixed fundamentals with real uncertainty.

Sentiment

fair
Sentiment3
Flat sentiment

Media sentiment is mildly positive, but retail sentiment is indeterminate, with no immediate catalysts.

The dominant driver is the trailing Q3 2026 print (announced 2026-10-28), which the tape actually rewarded — the stock rebounded sharply on improved adjusted EBITDA and free cash flow and five desks raised price targets — but that goodwill is now offset by a fresh Argus downgrade to Sell on 2026-11-02, leaving media sentiment determinate but essentially flat (baseline polarity_score ≈ +0.13 over 6 scored items vs scoring ≈ +0.15 over 10) with no forward-dated catalyst inside 30 days. No severe red flag fired (regulator_confirmed investigations: 0; only stale 2020/2022 matters), but a moderate conflicting-catalyst cap applies and retail sentiment is indeterminate after repeated Reddit access blocks.

Technical

good
Technical4
Strong uptrend

Price is above key moving averages with a rising ADX, indicating a strong uptrend and a pullback to support.

Technical score 4: trend and trend strength are exceptional — price 8.885 sits above SMA20 7.73, SMA50 6.71, SMA200 6.60, EMA9 8.74 and EMA21 7.98, and ADX 41.73 has climbed from 21.69 in nine sessions with price above all MAs (strong UP trend, not a directionless reading), while RSI 67.06 is strong but not overbought. The pullback is orderly: five sessions of contraction between 8.75 and 9.45 holding the rising 9-EMA after the 10-29 → 11-04 thrust from 6.88 to 9.75. One weak signal keeps it from a 5: MACD histogram has decayed from 0.38 (11-04) to 0.08 (11-12) and price sits below WMA9 9.00, DEMA14 9.28 and TEMA14 9.42, i.e. momentum is decelerating while the flag digests. Volume confirms digestion rather than distribution (flag sessions 3.5–4.9M shares vs 10.4M on the 11-05 reversal day).

You’re looking at 2026-11-12 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.